Physician profile
Ginger E Truitt
NPI 1376876136
$514.83
in general payments reported to CMS, 2019-2025
12 companies · $93.49 in 2025
The $93.49 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.59 · 2020: $15.97 · 2022: $25.03 · 2023: $160 · 2024: $165 · 2025: $93.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $165.10 | 2019-2025 | Aptima, Acessa Provu System, Thinprep 2000 Processor |
| Astellas Pharma US INC | $90.22 | 2024-2025 | Veozah |
| Organon LLC | $78.12 | 2023-2024 | Nexplanon |
| Coloplast Corp | $32.76 | 2023 | Altis |
| Pfizer INC. | $32.55 | 2023-2024 | |
| Baxter Healthcare | $24.96 | 2019 | |
| Evofem Biosciences, INC. | $23.12 | 2023 | Phexxi |
| Becton, Dickinson and Company | $18.96 | 2024 | Arista Ah Flexitip |
| Axonics, INC. | $15.97 | 2020 | |
| Exeltis, USA INC. | $13.71 | 2019 | |
| Aspira Women'S Health INC | $12.66 | 2024 | Ova1 |
| Channel Medsystems, INC. | $6.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Truitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.